Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Gives Parents Of Infants Less Than 6 Months Old H1N1 Vaccine Priority

This article was originally published in PharmAsia News

Executive Summary

Japan has decided to add parents of infants under six months old to the priority list for receiving an H1N1 flu vaccine once it is available. The Health, Labor and Welfare Ministry decided to add 1 million parents of infants less than a half-year-old to the second priority category because these infants are too young to be given the drug. Also in the second category, behind the million medical professionals, are 10 million people with chronic disease, a million pregnant women and 6 million infants older than six months. The third category will include students from primary through high school and then the elderly. (Click here for more

You may also be interested in...



A Runaway Hit In Us, Pfizer Gains EU Nod for Vyndaqel In Cardiomyopathy

Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by June.

First African Approvals For Merck’s Ebola Vaccine

Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa. 

Perrigo Launches OTC Viagra Rival In UK

Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.

UsernamePublicRestriction

Register

SC072798

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel